Evaxion A/S (NASDAQ: EVAX), a clinical-stage TechBio company, will provide a business update and report its third quarter 2025 financial results on November 6, 2025.
The company's Executive Management will host a conference call and webcast on the same day at 14:30 CET/08:30 EST to present the update and results, and answer questions.
No additional information is available at this time.
Author's summary: Evaxion announces Q3 2025 results.